Humoral immune responses in CD40 ligand-deficient mice

Individuals with X-linked hyper-IgM syndrome fail to express functional CD40 ligand (CD40L) and, as a consequence, are incapable of mounting protective antibody responses to opportunistic bacterial infections. To address the role of CD40L in humoral immunity, we created, through homologous recombination, mice deficient in CD40L expression. These mice exhibited no gross developmental deficiencies or health abnormalities and contained normal percentages of B and T cell subpopulations. CD40L-deficient mice did display selective deficiencies in humoral immunity; basal serum isotype levels were significantly lower than observed in normal mice, and IgE was undetectable. Furthermore, the CD40L-deficient mice failed to mount secondary antigen- specific responses to immunization with a thymus-dependent antigen, trinitrophenol-conjugated keyhole limpet hemocyanin (TNP-KLH). By contrast, the CD40L-deficient mice produced antigen-specific antibody of all isotypes except IgE in response to the thymus-independent antigen, DNP-Ficoll. These results underscore the requirement of CD40L for T cell-dependent antibody responses. Moreover, Ig class switching to isotypes other than IgE can occur in vivo in the absence of CD40L, supporting the notion that alternative B cell signaling pathways regulate responses to thymus-independent antigens.

[1]  F. Ramsdell,et al.  Recombinant CD40 ligand exerts potent biologic effects on T cells. , 1994, Journal of immunology.

[2]  H. Rammensee,et al.  The molecular interactions with helper T cells which limit antigen‐specific B cell differentiation , 1988, European journal of immunology.

[3]  H. Wortis Surface markers, heavy chain sequences and B cell lineages. , 1992, International reviews of immunology.

[4]  Broen Jj,et al.  Immunoglobulin transfer from immune-reconstituted SCID mice to nursing neonates: blood distribution of antibody and association with perinatal virus protection. , 1993 .

[5]  G. Ahmann,et al.  CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. , 1994, Journal of immunology.

[6]  T. Downie,et al.  Theory and Practice of Histological Techniques Edited by J.D. Bancroft & A. Stevens, Churchill Livingstone, Edinburgh, 740 pages, £55.00 , 1990 .

[7]  D. Gray,et al.  Activated human T cells express a ligand for the human B cell‐associated antigen CD40 which participates in T cell‐dependent activation of B lymphocytes , 1992, European journal of immunology.

[8]  I. Stamenkovic,et al.  A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  W. Paul,et al.  T cell regulation of IgG subclass antibody production in response to T- independent antigens , 1981, The Journal of experimental medicine.

[10]  H. Grey,et al.  Studies on the capacity of B cells to serve as antigen-presenting cells. , 1981, Journal of immunology.

[11]  P. Morrissey,et al.  Regulation of murine T cell proliferation by B cell stimulatory factor-1. , 1987, Journal of immunology.

[12]  W. Fanslow,et al.  CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40 , 1993, The Journal of experimental medicine.

[13]  B. Benacerraf,et al.  Cell interactions between histoincompatible T and B lymphocytes. The H-2 gene complex determines successful physiologic lymphocyte interactions. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P. Morrissey,et al.  Delayed allograft rejection in mice transgenic for a soluble form of the IL-4 receptor. , 1992, Cellular immunology.

[15]  C. Maliszewski,et al.  CD40L: a multi-functional ligand. , 1993, Seminars in immunology.

[16]  R. Callard,et al.  CD40 ligand and its role in X-linked hyper-IgM syndrome. , 1993, Immunology today.

[17]  C. Maliszewski,et al.  Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines , 1993, European journal of immunology.

[18]  P. Morrissey,et al.  Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Maliszewski,et al.  Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion , 1992, The Journal of experimental medicine.

[20]  C. Snapper,et al.  Towards a comprehensive view of immunoglobulin class switching. , 1993, Immunology today.

[21]  C. Maliszewski,et al.  The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2. , 1993, Journal of immunology.

[22]  Antonio Lanzavecchia,et al.  Antigen-specific interaction between T and B cells , 1985, Nature.

[23]  F. Melchers,et al.  T-cell-dependent B-cell stimulation is H-2 restricted and antigen dependent only at the resting B-cell level. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Snapper,et al.  Induction of IgG3 secretion by interferon gamma: a model for T cell- independent class switching in response to T cell-independent type 2 antigens , 1992, The Journal of experimental medicine.

[25]  R. de Waal Malefyt,et al.  IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. , 1993, International immunology.

[26]  R. Perlmutter,et al.  Subclass restriction of murine anti-carbohydrate antibodies. , 1978, Journal of immunology.

[27]  J. Mond,et al.  A Role for IFN‐γ and NK Cells in Immune Responses to T Cell‐Regulated Antigens Types 1 and 2 , 1987, Immunological reviews.

[28]  P. Appleby,et al.  Transmission of immunoglobulin to foetal and neonatal mice. , 1983, Journal of reproductive immunology.

[29]  F. W. Brambell The transmission of passive immunity from mother to young , 1970 .

[30]  F. Ramsdell,et al.  CD40 ligand acts as a costimulatory signal for neonatal thymic gamma delta T cells. , 1994, Journal of immunology.

[31]  R Kemler,et al.  The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. , 1985, Journal of embryology and experimental morphology.

[32]  F. Ramsdell,et al.  CD40 ligand is a T cell growth factor , 1993, European journal of immunology.

[33]  C. Snapper,et al.  IgE class switching is critically dependent upon the nature of the B cell activator, in addition to the presence of IL-4. , 1991, Journal of immunology.

[34]  M. Rudnicki,et al.  The mouse Pgk-1 gene promoter contains an upstream activator sequence. , 1991, Nucleic acids research.

[35]  P. Lipsky,et al.  T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3. , 1988, Journal of immunology.

[36]  C. Snapper,et al.  Dextran-conjugated anti-Ig antibodies as a model for T cell-independent type 2 antigen-mediated stimulation of Ig secretion in vitro. I. Lymphokine dependence. , 1991, Journal of Immunology.

[37]  E. Clark,et al.  Molecular and biological characterization of a murine ligand for CD40 , 1992, Nature.

[38]  W. Fanslow,et al.  Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. , 1993, Journal of immunology.

[39]  H. Dintzis,et al.  Picogram quantities of anti-Ig antibodies coupled to dextran induce B cell proliferation. , 1988, Journal of immunology.

[40]  A. Aruffo,et al.  The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. , 1993, Journal of immunology.

[41]  T. Owens A noncognate interaction with anti‐receptor antibody‐activated helper T cells induces small resting murine B cells to proliferate and to secrete antibody , 1988, European journal of immunology.

[42]  H. Tony,et al.  Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines. , 1988, Journal of immunology.

[43]  P. S. Kim,et al.  A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. , 1993, Science.

[44]  A. Aruffo,et al.  In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39 , 1993, The Journal of experimental medicine.

[45]  W. Cafruny,et al.  Immunoglobulin transfer from immune-reconstituted SCID mice to nursing neonates: blood distribution of antibody and association with perinatal virus protection. , 1993, Regional immunology.

[46]  A. Whitmore,et al.  B-1 cells are made, not born. , 1993, Immunology today.

[47]  E. Clark,et al.  Soluble forms of CD40 inhibit biologic responses of human B cells. , 1992, Journal of immunology.

[48]  Mario R. Capecchi,et al.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes , 1988, Nature.

[49]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[50]  T. Foy,et al.  Switching capacity of FcϵRII‐positive and ‐negative murine B cells , 1993 .